To access all features and enjoy the full functionality of this site, please ensure your browser is up-to-date. For IE8 users, the most recent version is IE11.

Blink® Triple Care Lubricating Eye Drops

Blink® Triple Care Lubricating Eye Drops

TREAT YOUR PATIENTS' MODERATE-TO-SEVERE DRY EYE SYMPTOMS

The first and only over-the-counter dry eye drop to combine polyethylene glycol with both hyaluronate and a nano-emulsion lipid,1* addressing both evaporative and aqueous-deficient dry eye2.

Blink® Triple Care is powered by our Dual-Action Moisture Seal Technology3. Here’s how these inactive ingredients work within the formulation:

  • Hyaluronic Acid binds moisture and helps boost hydration4-6
  • Lipid Nano-Emulsion helps protect against tear evaporation and locks in moisture6-9

 

The result is 3-in-1 extended relief4-11 for your patients:

  • Instantly Soothes4-11
  • Extra Long-lasting Hydration4-11
  • Locks in Moisture6-9

* Based on publicly available data as of 12/2022.

INDICATIONS AND IMPORTANT SAFETY INFORMATION FOR BLINK® TRIPLE CARE LUBRICATING EYE DROPS  

USES

Direction: Blink® Moisturizing, Blink® Intensive and Blink® Triple Care Drops are for the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun. Drops may be used as a protectant against further irritation.

Patients should stop use and contact their eye care professional if they experience eye pain, changes in vision, continued redness, or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

WARNINGS

- For external use only.
- To avoid contamination, do not touch tip of container to any surface. Replace cap after using.
- Do not use if product changes colour.

Stop use and ask an eye care professional if:

- You experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Keep out of the reach of children.

- If swallowed, get medical help or contact a Poison Control Centre right away.

DIRECTIONS

Shake well before use. Instill 1 or 2 drops in the affected eye(s) as needed or as directed by your eye care professional.

INACTIVE INGREDIENTS

Boric acid, castor oil, PEG 40 hydrogenated castor oil, polyethylene glycol 400, potassium chloride, purified water, sodium borate, sodium chloride, sodium chlorite (OcuPure® brand) as a preservative, sodium hyaluronate.

OTHER INFORMATION

  • Use only if tape seals on top and bottom flaps are intact.
  • Store at 0°– 30°C.

DRUG FACTS FOR BLINK® TRIPLE CARE LUBRICATING DROPS

DRUG FACTS

Active Ingredient . . . . . . .Polyethylene Glycol 400 0.25%

Purpose. . . . . . .Eye lubricant

REFERENCES

1. JJV Data on File 2022: Canada Market Research for Blink® Triple. 
2. 2012. Lemp, Miachael A. Distribution of Aqueous-Deficient and Evaporative Dry Eye in a Clinic-Based Patient Cohort: A Retrospective Study
3. JJV Data on File 2020. Blink Triple Care Lubricating Eye Drops - Consolidated, Approved Claims List.
4. Laurent TC. Structure of Hyaluronic Acid. In: EA Balazs (Ed.), Chemistry and Molecular Biology of Intracellular Matrix. Academic Press, London. 1970:703-732.
5. Aragona P, Papa V, Micali A, et al. Long Term Treatment with Sodium Hyaluronate-Containing Artificial Tears Reduces Ocular Surface Damage in Patients with Dry Eye. Br. J. Ophthamol. 2002;86(2):181-184. doi: 10.1136/bjo.86.2.181.
6. Prabhasawat P, Tesavibul N, Kasetsuwan K. Performance Profile of Sodium Hyaluronate in Patients with Lipid Tear Deficiency: Randomised, Double-Blind, Controlled, Exploratory Study. Br. J. Ophthalmol. 2007;91(1):47-50. doi: 10.1136/bjo.2006.097691.
7. Zheng X, Goto T, Shiraishi A, et al. In vitro efficacy of ocular surface lubricants against dehydration. Invest. Ophthalmol. Vis. Sci. 2013;32(9):1260-1264. doi: 10.1097/j.ico.0b013e31829cfd44.
8. Maissa C, Guillon M, Simmons P, et al. Effect of castor oil emulsion eyedrops on tear film composition and stability. Contact Lens Anterior Eye. 2010;33(2):76-82. doi: 10.1016/j.clae.2009.10.005.
9. Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. The Ocular Surface. 2017;15(3):276-283.​
10. Wasmanski AD and Kislan T. Cross-Over Evaluation of Polyethylene Glycol 400 (PEG-400) 0.4% and 0.25% Artificial Tears in Mild Dry Eye Patients. Invest. Ophthalmol. Vis. Sci. 2010;51(13):6263.
11. Montani G. Intrasubject Tear Osmolarity Changes with Two Different Types of Eye Drops. Optom. Vis. Sci. 2013;90(4): 372-377. doi: 10.1097/OPX.0b013e318288bdbe

PP2023CN4003